Hotel booking aggregator Trivago has admitted it may have misled consumers into believing they would find the lowest hotel rate on an initial search of its site and that it had breached the Australian Consumer Law.
Embattled wealth manager AMP has revealed its fees for no service scandal could cost the firm more than $1 billion in customer remediation, and that it might be facing another fees scandal.
The companies that own some of Australia’s largest intellectual property boutiques have agreed to a merger that will create a 349 employee-strong firm that’s a force to be reckoned with in the market for IP services in Asia Pacific.
US television giant Bravo can’t trade mark the phrase “Just Desserts” in Australia for its Top Chef reality cooking show spinoff, a sweet victory for the Seven Network, which challenged the mark.
A judge has taken a hatchet to Quinn Emanuel’s fees and the funder’s cut in a $12 million settlement of a class action against Bank of Queensland, a settlement which he previously described as one of the “worst” he’d ever seen.
GlaxoSmithKline has won approval for a patent for a vaccine to prevent a common respiratory virus affecting infants, beating out a challenge from a rival that has developed a competing vaccine.
A judge has signed off on an application to set aside a portion of a $30 million settlement in a class action over the 2004 Palm Island riots for financial counselling for registered group members, saying the court had the power to make the landmark order.
The High Court has shot down a request by the former head of food franchisor Retail Food Group that it relieve him from having to appear before a Parliamentary Committee looking into the Franchise Code of Conduct.
Squire Patton Boggs has refused a request by rival Phi Finney McDonald for the details of group members it signed up to its now stayed shareholder class action against GetSwift, a court has learned, in the latest show of resistance by the losing law firm.
An expert witness in an investor class action against Fitch Ratings over toxic financial products is no expert at all, the lead applicant told the court in contesting the admissibility of the expert’s evidence.